NPPB and atrial fibrillation: Patients in the reduced aMAPSE group were more likely to havepersistent AF, along with higher rates of diabetes and congestive heart failure.Additionally, these patients exhibited significantly elevated CHA2DS2-VAScscores, hemoglobin levels, and N-terminal pro b-type natriuretic peptide(NT-proBNP) levels (Table 5).